封面
市場調查報告書
商品編碼
1741550

全球體學研究人工智慧市場(按產品、技術平台、應用、最終用戶和地區分類)

Global AI in Omics Studies Market, By Offering, By Technology Platform, By Application, By End User, By Region

出版日期: | 出版商: Coherent Market Insights | 英文 172 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2025 年體學研究人工智慧的全球市場規模估計為 11.185 億美元,預計到 2032 年將達到 78.933 億美元,2025 年至 2032 年的年複合成長率(CAGR)為 32.2%。

報告範圍 報告詳細資訊
基準年 2024 2025年的市場規模 11.185億美元
效能數據 2020-2024 預測期 2025-2032
預測期:2025-2032年年複合成長率: 32.20% 2032年價值預測 78.933億美元

隨著人工智慧在基因組學、蛋白質組學和代謝體學等各體學領域的應用日益廣泛,全球體學研究領域人工智慧市場預計將顯著成長。人工智慧工具廣泛應用於巨量資料分析和精準醫療,以深入了解疾病並為患者制定個人化治療方法。人工智慧分析海量體學資料集和識別複雜模式的能力也促進了其在藥物研發和個人化治療等領域的應用。

市場動態:

推動全球體學研究人工智慧市場發展的關鍵因素包括製藥公司對藥物研發人工智慧的投資不斷增加、精準醫療需求日益成長以及政府對體學研究的資助不斷增加。此外,不斷成長的體學數據量以及有效利用這些數據的需求正在推動人工智慧的應用。然而,對資料隱私和安全的擔憂、不願採用新技術以及熟練人工智慧人才的短缺,都是阻礙市場成長的因素之一。同時,雲端基礎的體學數據分析平台的興起,以及人工智慧和醫療保健領域新興企業生態系統的不斷擴張,預計將為市場參與者提供巨大的成長機會。

此外,近年來,隨著次世代定序儀的出現以及定量蛋白質體學和代謝體學技術的進步,體學研究發生了革命性的變化。這些高通量技術使得能夠以前所未有的規模和速度產生大量多體學資料。全基因組和全外EXOME序列測定等技術不僅擴大用於研究目的,也擴大應用於臨床診斷和預後預測。核糖核酸序列測定等技術使得在單細胞層級上對轉錄組進行分析成為可能,從而提供了特定細胞類型和疾病狀態的詳細資訊。 SWATH-MS 等代謝體學技術提高了蛋白質的覆蓋率和定量能力。代謝組學技術現在可以同時識別和定量生物樣本中的多種代謝物。這些先進的定量體學技術正在促進多體學整合研究,並為生物系統提供更深入的見解。預計此類大規模、定量、整合的體學資料集將在未來幾年推動對疾病機制、生物標記和治療標靶的重大發現和洞察。這將進一步推動各疾病領域的體學研究和應用的發展。

本研究的主要特點

  • 本報告對全球體學研究人工智慧市場進行了詳細分析,並提供了預測期 2025-2032 的市場規模和年複合成長率(CAGR),假設 2024 年為基準年。
  • 它還揭示了各個領域的潛在商機,並說明了該市場的引人注目的投資提案矩陣。
  • 它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景和主要企業採用的競爭策略的重要見解。
  • 全球體學研究人工智慧市場的主要企業是根據公司亮點、產品系列、關鍵亮點、財務績效和策略等參數進行的分析。
  • 本報告的見解將使負責人和企業經營團隊能夠就未來的產品發布、新興車型、市場擴張和行銷策略做出明智的決策。
  • 全球體學研究人工智慧市場報告迎合了該行業的各個相關人員,例如投資者、供應商、產品製造商、經銷商、新進業者和金融分析師。
  • 相關人員可以透過用於分析全球體學研究人工智慧市場的各種策略矩陣來簡化決策。

目錄

第1章 研究目的與前提

  • 研究目標
  • 先決條件
  • 簡稱

第2章 市場展望

  • 報告描述
    • 市場定義和範圍
  • 執行摘要
  • Coherent Opportunity Map(COM)

第3章市場動態、法規與趨勢分析

  • 市場動態
  • 主要亮點
  • 監管情景
  • 近期動態
  • PEST分析
  • 波特分析
  • 合併、收購和合作

第4章體學研究人工智慧的全球市場-冠狀病毒(COVID-19)大流行的影響

  • COVID-19流行病學
  • 供需側分析
  • 經濟影響

第5章。 2020 年至 2032 年全球體學研究人工智慧市場(按產品提供)

  • 軟體
  • 服務

第6章。 2020 年至 2032 年按技術平台分類的體學研究人工智慧市場

  • 定序
  • 表觀基因
  • 蛋白質體學
  • 代謝體學
  • 其他(轉錄組學等)

第7章 2020 年至 2032 年體學研究人工智慧的全球市場(按應用)

  • 腫瘤學
  • 感染疾病
  • 神經病學
  • 心血管疾病
  • 免疫學
  • 其他(藥物基因組學等)

第 8 章。 2020 年至 2032 年全球體學研究人工智慧市場(按最終用戶分類)

  • 學術和研究機構
  • 生物製藥公司
  • 其他(合約研究組織等)

第9章 2020 年至 2032 年體學研究人工智慧全球市場(按地區分類)

  • 北美洲
      • 美國
      • 加拿大
  • 歐洲
      • 德國
      • 英國
      • 西班牙
      • 法國
      • 義大利
      • 俄羅斯
      • 其他歐洲國家
  • 亞太地區
      • 中國
      • 印度
      • 日本
      • 澳洲
      • 韓國
      • ASEAN
      • 其他亞太地區
  • 拉丁美洲
      • 巴西
      • 阿根廷
      • 墨西哥
      • 其他拉丁美洲
  • 中東
      • 海灣合作理事會國家
      • 以色列
      • 其他中東地區
  • 非洲
      • 北非
      • 中部非洲
      • 南非

第10章 競爭格局

  • 公司簡介
    • Thermo Fisher Scientific
    • Agilent Technologies
    • Illumina
    • BGI Genomics
    • Dassault Systemes
    • Qiagen
    • Waters Corporation
    • GE Healthcare
    • Amazon Web Services, Inc
    • Bruker
    • Danaher

第 11 章 章節

  • 參考
  • 調查方法
  • 關於出版商
簡介目錄
Product Code: CMI6516

Global AI in Omics Studies Market is estimated to be valued at USD 1,118.5 Mn in 2025 and is expected to reach USD 7,893.3 Mn by 2032, growing at a compound annual growth rate (CAGR) of 32.2% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 1,118.5 Mn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 32.20% 2032 Value Projection: USD 7,893.3 Mn

The global AI in omics studies market is expected to see significant growth due to the increasing adoption of artificial intelligence in various omics fields such as genomics, proteomics, and metabolomics. AI tools are being widely used for big data analytics and precision medicine to gain deeper insights into diseases and develop personalized treatment options for patients. The ability of AI to analyze massive omics datasets and identify complex patterns is also propelling its usage in areas like drug discovery and personalized therapeutics.

Market Dynamics:

The key drivers fueling the global AI in omics studies market include growing investments by pharmaceutical companies in AI for drug discovery, rising demand for precision medicine, and increasing government funding for omics research. Additionally, the growing volumes of omics data being generated and the need to leverage this data effectively are driving the adoption of AI. However, data privacy and security concerns, reluctance to adopt new technologies, and a lack of a skilled AI workforce are some of the factors hindering market growth. Meanwhile, the emergence of cloud-based omics data analytics platforms and the expansion of the startup ecosystem in the AI and healthcare spaces are expected to create significant growth opportunities for market players.

Moreover, with the advent of next-generation sequencing and advancements in quantitative proteomics and metabolomics technologies, omics studies have been revolutionized in recent years. These high-throughput technologies have enabled the generation of massive amounts of multi-omics data at an unprecedented scale and speed. Technologies like whole genome and whole exome sequencing are increasingly used not just for research purposes but also in clinical settings for diagnostics and prognostics. Technologies such as Ribonucleic acid sequencing have enabled the profiling of transcriptomes at the single-cell level, providing details into specific cell types, disease conditions, etc. Proteomics technologies like SWATH-MS have improved protein coverage and quantitation capabilities. Metabolomics technologies are now capable of identifying and quantifying several metabolites simultaneously from biological samples. These advancing quantitative omics technologies are facilitating multi-omics integration studies and providing deeper insights into biological systems. The availability of such large-scale, quantitative, and integrated omics datasets is expected to drive significant discovery and insights into disease mechanisms, biomarkers, and therapeutic targets in the coming years. This will further fuel the growth in omics based research and applications across various disease areas.

Key features of the study:

  • This report provides in-depth analysis of the global AI in omics studies market, and provides market size (US$ Mn) and compound annual growth rate (CAGR %) for the forecast period 2025-2032, considering 2024 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global AI in omics studies market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Thermo Fisher Scientific, Agilent Technologies, Illumina, BGI Genomics, Dassault Systemes, Qiagen, Waters Corporation, GE Healthcare, Amazon Web Services, Inc., Bruker, and Danaher
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • Global AI in omics studies market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global AI in omics studies market

Detailed Segmentation:

  • Global AI in Omics Studies Market, By Offering
    • Software
    • Services
  • Global AI in Omics Studies Market, By Technology Platform
    • Sequencing
    • Epigenomics
    • Proteomics
    • Metabolomics
    • Others (Transcriptomics, among others)
  • Global AI in Omics Studies Market, By Application
    • Oncology
    • Infectious Diseases
    • Neurology
    • Cardiovascular Diseases
    • Immunology
    • Others (Pharmacogenomics, among others)
  • Global AI in Omics Studies Market, By End User
    • Academic and Research Institutes
    • Biopharmaceutical Company
    • Others (Contract Research Organizations, among others)
  • Global AI in Omics Studies Market, By Region
    • North America
    • Latin America
    • Europe
    • Asia Pacific
    • Middle East
    • Africa
  • Company Profiles
    • Thermo Fisher Scientific.
    • Agilent Technologies
    • Illumina
    • BGI Genomics
    • Dassault Systemes
    • Qiagen
    • Waters Corporation
    • GE Healthcare
    • Amazon Web Services, Inc
    • Bruker
    • Danaher

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Global AI in Omics Studies Market, By Offering
    • Global AI in Omics Studies Market, By Technology Platform
    • Global AI in Omics Studies Market, By Application
    • Global AI in Omics Studies Market, By End User
    • Global AI in Omics Studies Market, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Growing genetic/genomic data and increasing investments
    • High setup costs and lack of infrastructure
    • Scope for AI in drug discovery and vaccine development
  • Key Highlights
  • Regulatory Scenario
  • Recent Trends
  • PEST Analysis
  • PORTER's Analysis
  • Mergers, Acquisitions, and Collaborations

4. Global AI in Omics Studies Market- Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Global AI in Omics Studies Market, By Offering, 2020-2032, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Software
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Services
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)

6. Global AI in Omics Studies Market, By Technology Platform, 2020-2032, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Sequencing
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Epigenomics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Proteomics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Metabolomics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Others (Transcriptomics, among others)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)

7. Global AI in Omics Studies Market, By Application, 2020-2032, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Oncology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Infectious Diseases
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Neurology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Cardiovascular Diseases
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Immunology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Others (Pharmacogenomics, among others)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)

8. Global AI in Omics Studies Market, By End User, 2020-2032, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Academic and Research Institutes
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Biopharmaceutical Company
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Others (Contract Research Organizations, among others)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)

9. Global AI in Omics Studies Market, By Region, 2020-2032, (US$ Mn)

  • Introduction
    • Market Share Analysis, By Region, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, For Region, 2021 -2032
    • Country Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Offering, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology Platform, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
      • U.S.
      • Canada
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Offering, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology Platform, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
      • Germany
      • U.K.
      • Spain
      • France
      • Italy
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Offering, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology Platform, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Offering, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology Platform, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
      • Brazil
      • Argentina
      • Mexico
      • Rest of Latin America
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Offering, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology Platform, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
      • GCC Countries
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Offering, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology Platform, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020-2032,(US$ Mn)
      • North Africa
      • Central Africa
      • South Africa

10. Competitive Landscape

  • Company Profile
    • Thermo Fisher Scientific
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
    • Agilent Technologies
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
    • Illumina
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
    • BGI Genomics
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
    • Dassault Systemes
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
    • Qiagen
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
  • Strategies
    • Waters Corporation
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
    • GE Healthcare
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
    • Amazon Web Services, Inc
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
    • Bruker
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
    • Danaher
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
  • Analyst Views

11. Section

  • References
  • Research Methodology
  • About us